【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets/Categories Covered 12
3.1 Dental Devices 12
3.1.1 CAD/CAM Dental Systems 12
3.1.2 Crowns and Bridges 12
3.1.3 Dental Implants 12
4 Company Snapshot 13
4.1 Key Facts 13
4.2 Company Overview 13
4.3 Financial Performance 13
4.4 SWOT Snapshot 13
5 Business Description 14
5.1 Business Overview 14
5.2 Dental Solutions 14
5.2.1 Overview 14
5.2.2 Financials 15
5.2.3 Market View 15
5.3 Major Products and Services 15
5.3.1 Overview 15
6 History 16
7 SWOT Analysis 19
7.1 Overview 19
7.2 Nobel Biocare Holding AG Strengths 19
7.2.1 Broad Product Portfolio 19
7.2.2 Geographic Diversity 20
7.2.3 Emphasis on Research and Development 20
7.3 Nobel Biocare Holding AG Weaknesses 20
7.3.1 Low Debt to Equity Ratio 20
7.3.2 Financial Performance 20
7.3.3 Legal Proceedings 20
7.4 Nobel Biocare Holding AG Opportunities 21
7.4.1 New Product Launches 21
7.4.2 Growing Dental Devices Market 21
7.4.3 Growth in Emerging Markets 21
7.4.4 Growing Aged Population 22
7.5 Nobel Biocare Holding AG Threats 22
7.5.1 Competitive Landscape 22
7.5.2 Stringent Government Regulations 22
7.5.3 Rapid Technological Change 22
8 Competitors 23
9 Competitive Landscape 24
9.1 Dental Devices (CAD/CAM Dental Systems), Global, Market Share (%), 2011 24
9.2 Nobel Biocare Holding AG, Dental Devices (CAD/CAM Dental Systems), by Region, Market Share (2011) 26
9.3 Nobel Biocare Holding AG, Dental Devices (CAD/CAM Dental Systems), by Country, Market Share (2011) 27
9.4 Dental Devices (Crowns and Bridges),Global, Market Share (%), 2011 29
9.5 Nobel Biocare Holding AG, Dental Devices (Crowns and Bridges),by Region, Market Share (2011) 31
9.6 Nobel Biocare Holding AG, Dental Devices (Crowns and Bridges), by Country, Market Share (2011) 32
9.7 Dental Devices (Dental Implants),Global, Market Share (%), 2011 34
9.8 Nobel Biocare Holding AG, Dental Devices (Dental Implants),by Region, Market Share (2011) 36
9.9 Nobel Biocare Holding AG, Dental Devices (Dental Implants), by Country, Market Share (2011) 37
10 Nobel Biocare Holding AG Medical Equipment Market Share Analysis by Category 39
10.1 Nobel Biocare Holding AG, Dental Devices, Global, Category Revenue Share (2011) 39
10.2 Nobel Biocare Holding AG, Asia-Pacific, Category Revenue Share (2011) 41
10.2.1 Nobel Biocare Holding AG, Australia, Category Revenue Share (2011) 43
10.2.2 Nobel Biocare Holding AG, China, Category Revenue Share (2011) 45
10.2.3 Nobel Biocare Holding AG, India, Category Revenue Share (2011) 47
10.2.4 Nobel Biocare Holding AG, Japan, Category Revenue Share (2011) 49
10.2.5 Nobel Biocare Holding AG, Other Asia-Pacific, Category Revenue Share (2011) 51
10.3 Nobel Biocare Holding AG, Europe, Category Revenue Share (2011) 53
10.3.1 Nobel Biocare Holding AG, France, Category Revenue Share (2011) 55
10.3.2 Nobel Biocare Holding AG, Germany, Category Revenue Share (2011) 57
10.3.3 Nobel Biocare Holding AG, Italy, Category Revenue Share (2011) 59
10.3.4 Nobel Biocare Holding AG, Spain, Category Revenue Share (2011) 61
10.3.5 Nobel Biocare Holding AG, United Kingdom, Category Revenue Share (2011) 63
10.3.6 Nobel Biocare Holding AG, Other Europe, Category Revenue Share (2011) 65
10.4 Nobel Biocare Holding AG, Middle East and Africa, Category Revenue Share (2011) 67
10.5 Nobel Biocare Holding AG, North America, Category Revenue Share (2011) 69
10.5.1 Nobel Biocare Holding AG, Canada, Category Revenue Share (2011) 71
10.5.2 Nobel Biocare Holding AG, United States, Category Revenue Share (2011) 73
10.6 Nobel Biocare Holding AG, South and Central America, Category Revenue Share (2011) 75
10.6.1 Nobel Biocare Holding AG, Brazil, Category Revenue Share (2011) 77
10.6.2 Nobel Biocare Holding AG, Other South and Central America, Category Revenue Share (2011) 79
11 Key Employees 81
12 Key Employee Biographies 82
13 Company Statement 83
14 Locations And Subsidiaries 85
14.1 Head Office 85
14.2 Other Locations & Subsidiaries 85
15 Financial Deals Landscape 87
15.1 Nobel Biocare Holding AG, Deals Volume Summary, 2007 to YTD 2013 87
16 Nobel Biocare Holding AG Detailed Deal Summary 89
16.1 Partnerships 89
16.1.1 Materialise Dental Enters Into Licensing Agreement With Nobel Biocare 89
16.1.2 Ceragenix Pharma Signs An Agreement With Nobel Biocare 90
16.1.3 Nobel Biocare Enters Into An Agreement With XCPT 91
16.1.4 Nobel Biocare Holding Enters Into An Agreement With Ivoclar Vivadent 92
16.1.5 Nobel Biocare Enters Into Co-Development Agreement With Optical Metrology 93
16.1.6 Nobel Biocare Signs An Agreement With Stockholm University 94
16.1.7 Nobel Biocare Announces Public Offering Of Bonds For $136 Million 95
16.1.8 Nobel Biocare Holdings Completes Public Offering Of Convertible Bonds For $331 Million 96
16.2 Acquisition 97
16.2.1 Nobel Biocare Acquires BioCad Medical 97
16.2.2 Nobel Biocare Holding Acquires Medicim 98
16.2.3 Nobel Biocare Holding Acquires Implant Master 99
16.2.4 Nobel Biocare Acquires AlphaBioTec 100
17 Recent Developments 101
17.1 Strategy And Business Planning 101
17.1.1 Feb 23, 2010: Nobel Biocare Signs Partnership Agreement With Noritake 101
17.1.2 Jan 11, 2010: Nobel Biocare Establishes Preferred Partner Program With Ivoclar Vivadent 102
17.1.3 Feb 22, 2008: Nobel Biocare Establishes Own Sales Organization In Hungary 103
17.2 Financial Announcements 103
17.2.1 Nov 08, 2012: Nobel Biocare Reports Revenue Of €131m In Q3 2012 103
17.2.2 Aug 22, 2012: Nobel Biocare Reports Revenue Of €149m In Q2 2012 104
17.2.3 Apr 27, 2012: Nobel Biocare Reports Revenue Of €147.6m In Q1 2012 104
17.2.4 Feb 09, 2012: Nobel Biocare Reports Revenue Of €569.2m In 2011 105
17.2.5 Nov 08, 2011: Nobel Biocare Reports Revenues Of €128.2m In Q3 2011 106
17.2.6 Aug 12, 2011: Nobel Biocare Reports Revenues Of €142.9m In Q2 2011 107
17.2.7 Apr 28, 2011: Nobel Biocare Reports Revenues Of €143.5m In Q1 2011 109
17.2.8 Feb 17, 2011: Nobel Biocare Reports Revenues Of €576.6m In 2010 110
17.2.9 Nov 03, 2010: Nobel Biocare Reports Revenues Of €131.7m In Q3 2010 110
17.2.10 Aug 11, 2010: Nobel Biocare Reports Profit Of EUR19.59 Million In Q2 2010 111
17.2.11 Apr 28, 2010: Nobel Biocare Reports Net Profit Of EUR38.7 Million In Q1 2010 112
17.2.12 Feb 10, 2010: Nobel Biocare Reports Net Income Of EUR105.8 Million In 2009 113
17.2.13 Nov 04, 2009: Nobel Biocare Reports Net Profit Of EUR33.6 Million In Q3 2009 115
17.2.14 Oct 19, 2009: Nobel Biocare Appoints William (Bill) Ryan As President And General Manager, North America 116
17.2.15 Aug 12, 2009: Nobel Biocare Posts Revenues Of EUR153.5 Million In Q2 2009 116
17.2.16 Apr 29, 2009: Nobel Biocare Posts Net Profit Of EUR18 Million In Q1 2009 117
17.2.17 Feb 11, 2009: Nobel Biocare Reports 2008 Results 118
17.2.18 Nov 03, 2008: Nobel Biocare Reports 3Q 2008 Results 120
17.2.19 Aug 11, 2008: Nobel Biocare Reports 2Q 2008 Results 122
17.2.20 Apr 24, 2008: Nobel Biocare Reports Q1 2008 Results 124
17.2.21 Feb 11, 2008: Nobel Biocare Declares 2007 Results 125
17.2.22 Oct 30, 2007: Nobel Biocare Reports Q3 2007 Results 126
17.2.23 Aug 09, 2007: Nobel Biocare Reports Q2 2007 Results 128
17.2.24 Apr 26, 2007: Nobel Biocare Reports Q1 2007 Results 129
17.2.25 Feb 08, 2007: Nobel Biocare Reports 2006 Results 129
17.2.26 Oct 19, 2006: Nobel Biocare Reports Q3 2006 Results 130
17.2.27 Aug 10, 2006: Nobel Biocare Reports Q2 2006 Results 131
17.2.28 May 03, 2006: Nobel Biocare Approves Dividend 132
17.2.29 May 03, 2006: Nobel Biocare Reports Q1 2006 Results 132
17.3 Research And Development 133
17.3.1 Oct 24, 2007: Nobel Biocare Signs Agreement With College Of Dentistry To Develop Predoctoral Curriculum 133
17.3.2 Feb 01, 2007: Nobel Biocare And Stockholm University Signs Research Partnership Agreement 134
17.4 Corporate Communications 134
17.4.1 Jul 06, 2012: Nobel Biocare Announces Resignation Of Dirk Kirsten As CFO 134
17.4.2 Mar 06, 2012: Nobel Biocare Appoints Frank Mengis As Senior Vice President, Global Operations 134
17.4.3 Jul 04, 2011: Nobel Biocare Names Michel Orsinger New Chairman 135
17.4.4 Feb 16, 2011: Nobel Biocare Appoints Richard Laube As New CEO 135
17.4.5 Dec 01, 2010: Nobel Biocare Announces Executive Changes 136
17.4.6 Oct 25, 2010: Nobel Biocare Announces Resignation Of Robert Gottlander As Executive Vice President Key Account Management 136
17.4.7 Apr 05, 2010: Nobel Biocare Elects New Board Members 137
17.4.8 Jul 11, 2009: Nobel Biocare Chairman To Step Down By March 2010 137
17.4.9 Apr 29, 2009: Nobel Biocare Plans To Reduce Workforce In Q2 2009 137
17.4.10 Mar 05, 2008: Nobel Biocare Announces Management Changes 137
17.4.11 Feb 25, 2008: Nobel Biocare To Delist From OMX Exchange 138
17.4.12 Oct 15, 2007: Nobel Biocare Appoints Head Of Business Development & Strategic Planning 138
17.4.13 Jul 30, 2007: Nobel Biocare Appoints New CEO 138
17.4.14 May 03, 2006: Nobel Biocare Elects New Board Members 139
17.5 Legal and Regulatory 139
17.5.1 Jul 05, 2010: California Dentist Files Class Action Suit Against Nobel Biocare Holding 139
17.5.2 Sep 14, 2009: Nobel Biocare And Materialise Dental Settle Patent Dispute 139
17.5.3 Sep 03, 2008: Nobel Biocare Settles Lawsuit Against Keystone Dental 139
17.6 Product News 140
17.6.1 Oct 06, 2010: Nobel Biocare Launches Replace Select TC One-Stage Overdenture Solution 140
17.6.2 Jan 31, 2008: Nobel Biocare Distributes Updated Information To Regulatory Bodies And Customers On Nobeldirect One Piece Implant 140
17.6.3 Jan 31, 2008: Nobel Biocare Updates Information On NobelPerfect One-piece Implant 141
17.6.4 Oct 15, 2007: Procera Software Clinical Design 2.0 – Better Features For Enhanced Nobelguide Treatment Planning 141
17.6.5 Oct 15, 2007: Procera Software Lab Design 2.0 – Streamlined And Improved Productivity Means Greater Profitability 141
17.6.6 Feb 22, 2007: Nobel Biocare Introduced Its Procera Implant Bridge Zirconia 141
17.6.7 Feb 22, 2007: Nobel Biocare Introduces Its Procera Bridge Zirconia 141
17.7 Other Significant Developments 142
17.7.1 Nov 22, 2010: Nobel Biocare Extends Syndicated Loan Facility 142
17.7.2 Nov 17, 2010: Nobel Biocare Signs MOU To Support P-I Branemark Institute Bauru In Brazil 142
17.7.3 Jul 09, 2009: CSC signs IT services outsourcing contract with Nobel Biocare 142
17.7.4 Jul 09, 2009: CSC Signs Seven-Year IT Outsourcing Agreement With Nobel Biocare 143
17.7.5 Mar 18, 2009: Nobel Biocare Signs Syndicated Loan Facility With Six International Banks 143
18 Appendix 144
18.1 Research Methodology 145
18.2 Secondary Research 145
18.3 Primary Research 145
18.4 Models 146
18.5 Forecasts 146
18.6 Expert Panels 146
18.7 GlobalData Consulting 146
18.8 Currency Conversion 147
18.9 Contact Us 148
18.10 Disclaimer 148
【レポート販売概要】
■ タイトル：Nobel Biocare Holding AG：市場シェア分析■ 英文：Nobel Biocare Holding AG Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160529
■ 調査対象地域：グローバル
- 初心者用顕微鏡の世界市場2016-2020About Beginner Microscope A beginner microscope falls under the category of simple optical microscopes or magnifying toy microscopes and are used by students in primary and secondary schools. In comparison with compound microscopes, beginner microscopes are low power, low-cost instruments that have limited resolving power and application. The end-users of these microscopes are children in the age …
- カーボンブラック(BC)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world carbon black market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insi …
- テニス用品の世界市場The expansion of the global tennis equipment industry is forecast to reach 0.8% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 1.8%. Currently, tennis balls account for 50.6% of the global demand while tennis rackets have a 49.4% share of the market. China, France, Germany, Japan and the United States represent the largest tennis equipment mar …
- 572-Trii (HIV)：市場予測と分析（～2022）572-Trii (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “572-Trii (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a d …
- 世界のステアリン酸カルシウム市場2015The Global Calcium Stearate Industry Report 2015 is a professional and in-depth study on the current state of the Calcium Stearate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Calcium Stearate market analysis is provided for the international markets including development trends, competitive lan …
- 世界の無線LANホットスポット市場動向（2012-2016）TechNavio's analysts forecast the Global Wi-Fi Hotspot market to grow at a CAGR of 0.84 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased use of mobile devices. The Global Wi-Fi Hotspot market has also been witnessing increased adoption of Wi-Fi services in smart homes. However, security issues associated with the use of wireless networks …
- 事業提携・ライセンシング・投資・M&A動向（四半期別）：Q2 2013Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides …
- Cimarex Energy Co.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Cimarex Energy Co. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Cimarex Energy Co. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- 公共事業向けドローンの世界市場予測（～2023年）“The utility drones market is projected to grow at a CAGR of 37.34% from 2018 to 2023.” The utility drones market is projected to reach USD 538.6 million by 2023, from an estimated USD 110.2 million in 2018, at a CAGR of 37.34% from 2018 to 2023. This growth can be attributed to the rising demand for minimizing outages related to transmission and distribution infrastructure, focus on time and cost …
- 中・高精度GPS（位置情報システム）の世界市場The factors such as ongoing developments to improve the overall GPS infrastructure, technological advancements and GPS augmentation, and availability of more cost-effective GPS solutions are driving the mid and high level precision GPS market. Ongoing developments in the GPS technology are likely to enhance coverage and reliability. It is expected that enhancements in terms of coverage would drive …
- 世界の不正行為検知及び予防市場動向と予測（2013-2018）：Updated VersionFraud detection and prevention solutions are the offerings from IT vendors to the enterprises which helps enterprises to detect frauds or prevent occurrences of frauds at early stages. In this report fraud detection and prevention solutions refer to the IT solutions and systems which are used to analyze the data and find anomalies and patterns (to find deterrence from usual course) and the solutio …
- 船舶用照明の世界市場予測（～2027年）Increasing demand for Maritime transportation to drive the Marine lighting marketThe marine lighting market is projected to grow to USD 495 million by 2027 from USD 328 million in 2019, at a CAGR of 5.3% during the forecast period. The increasing demand for lighting is driven mainly by the growing usage of LEDs, and the stringent regulations for the marine industry, increasing demand for luxury ya …
- Tullow Oil plc：石油・ガスバリューチェーン分析レポート2013Tullow Oil plc Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Tullow Oil plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Tullow Oil plc”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s …
- 世界の遺伝子治療市場展望：腫瘍/感染症/遺伝病/心臓血管疾患/糖尿病/神経疾患治療Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for ‘difficult to cure’ diseases. The gene therapy market, presenting a few marketable products and being nascent in terms of revenue generation, holds tremen …
- ナトリウム低減成分（アミノ酸、ミネラル塩、イースト抽出物）のグローバル市場Sodium reduction ingredients, which are used to reduce the salt content in the food products, form an integral part of the global food additives industry. They help reduce or replace the salt content in food products. Due to the rising awareness about the ill effects of excessive sodium intake, this market is heading towards its growth. Also, government interventions and multi-sector efforts by va …
